MoneyWorks4Me

Sun Pharmaceutical Industries informs about company updates

20 Dec 2016 Evaluate

Sun Pharmaceutical Industries has informed that one of the Company’s wholly-owned subsidiaries has voluntarily requested the USFDA to withdraw approval for 28 Abbreviated New Drug Applications (ANDAs). These older drug products belong to erstwhile Ranbaxy Laboratories and are not being marketed in the US since 2008.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1801.00
Dr. Reddys Labs. 1209.15
Cipla 1343.00
Lupin 2035.00
Zydus Lifesciences 1160.00
View more..